Fusarium Solani: Plant & Human Infections

Fusarium solani is one of the few fungal pathogens that can infect both plants and humans with roughly equal competence, causing devastating root rots in crops and serious eye and bloodstream infections in people. What makes this organism particularly challenging is that it is not actually a single species but a sprawling complex of closely related fungi, many of which are resistant to the drugs and fungicides used to control them. Its ability to thrive in soil, water pipes, and hospital drains means that exposure is difficult to avoid, and its cross-kingdom virulence makes it a problem for farmers and physicians alike.

Not One Species but a Complex of Many

What scientists once called “Fusarium solani” has turned out to be a collection of dozens of distinct but closely related species, now formally grouped as the Fusarium solani species complex (FSSC). Genetic sequencing has revealed strongly supported phylogenetic species within the complex, though the taxonomy still lags behind the molecular data. A study examining 55 FSSC strains from Malaysia classified them into four described species and one previously unknown species, using both physical characteristics and DNA sequencing of conserved gene regions.

This distinction matters for human health. Two of the most clinically relevant species within the complex, Fusarium keratoplasticum and Fusarium petroliphilum, are among the most frequently isolated fusaria in plumbing drain biofilms and in outbreaks of contact lens-associated eye infections.² Identifying which species within the complex is responsible for a given infection can influence treatment decisions, since antifungal susceptibility varies between them.

Hiding in Plain Sight in Water and Drains

One of the more unsettling facts about the FSSC is how thoroughly it colonizes built water systems. A survey of 471 plumbing drains across 131 buildings in the United States found that about two-thirds of sinks and 80 percent of buildings harbored at least one Fusarium species.³ These were mostly bathroom sinks in ordinary homes and public buildings, not places most people associate with dangerous fungi.

Hospital water systems are also colonized. In a French university hospital, every tap-water sample tested positive for Fusarium in two units, with concentrations reaching up to 100,000 colony-forming units per liter.⁴ Municipal sewage tells a similar story. All six urban wastewater treatment plants tested in one California study contained FSSC in their incoming water, and the fungus was also detected in community shower drains.⁵ Wastewater treatment does reduce the load in both liquid and solid fractions, but it does not eliminate the organism entirely.

For most healthy people, contact with Fusarium-laden tap water is harmless. The fungus needs a way in, whether through a scratch on the eye’s surface, an open wound, or a severely weakened immune system. But the sheer ubiquity of the organism in water infrastructure helps explain why hospital-acquired Fusarium infections keep occurring, and why investigations of infection clusters often trace back to drain outlets in patient rooms.⁶

Damage to Crops Around the World

In agriculture, members of the FSSC cause root rot, crown rot, and wilt in a wide range of economically important plants. The disease typically starts below ground, attacking feeder roots and cortical tissue before working its way into the plant’s vascular system. By the time above-ground symptoms appear, the damage is often extensive.

Strawberry growers in southwestern Spain documented crown and root rot caused by F. solani, with infected plants showing foliage wilt, stunting, and death of older leaves. Internal tissues developed an orange-to-brown discoloration, and new feeder root production was almost nonexistent.⁷ In Turkey, dry root rot caused by F. solani has been described as one of the most dangerous diseases of citrus, causing light purple vascular discolorations and dry decay of fibrous roots across affected orchards.⁸

The pathogen’s playbook in plants involves more than brute-force tissue destruction. Research on passion fruit stem rot found that F. solani secretes cell wall-degrading enzymes, particularly pectin lyases, and appears to manipulate the plant’s own hormone signaling pathways. Levels of stress-response hormones correlated strongly with the abundance of these enzymes, suggesting that the fungus hijacks the plant’s defense systems to ease its entry.⁹

Human Infections From Eye to Bloodstream

In people, F. solani complex infections fall into two broad categories: localized disease in otherwise healthy individuals and invasive or disseminated disease in immunocompromised patients. The distinction between these two forms depends largely on immune status and how the fungus gets in.¹⁰

Fungal keratitis, an infection of the cornea, is the most common localized form. It typically follows some kind of eye trauma or contact lens use. In one reported case, a 37-year-old man in rural Ecuador developed a large corneal ulcer after herbal juice was rubbed on his face during a traditional healing practice. The ulcer covered roughly 60 percent of the corneal surface and had a distinctive whitish, cottony appearance.¹¹ Research into the corneal immune response to F. solani has shown that infection triggers a heavy influx of inflammatory macrophages into corneal tissue, replacing the regulatory T cells that predominate in healthy corneas.¹² This inflammatory response contributes to the tissue damage that makes Fusarium keratitis particularly aggressive compared to many bacterial eye infections.

Invasive fusariosis is a far more dangerous condition. It primarily affects patients with blood cancers undergoing chemotherapy and recipients of bone marrow transplants. The typical presentation involves painful skin lesions scattered across the body, positive blood cultures for Fusarium (an unusual finding for mold infections), and lung involvement.¹³ In one case series, the overall mortality rate was 37 percent, but for disseminated disease specifically, mortality reached 83 percent.¹⁴ Among patients whose white blood cell counts remain critically low, disseminated fusariosis is nearly universally fatal.¹⁰

The 2005–2006 Contact Lens Keratitis Outbreak

Fusarium’s capacity for surface colonization was demonstrated dramatically during a global outbreak of fungal keratitis in 2005 and 2006. More than 250 cases were reported worldwide, primarily linked to a specific Bausch & Lomb contact lens disinfecting solution.¹⁵ Both F. solani and F. oxysporum were identified as the causative organisms, and investigations showed that the infections involved biofilm formation on the lens surface.¹⁶

Laboratory studies confirmed that clinical Fusarium isolates form biofilms on all types of soft contact lenses, with the biofilm structure varying depending on the lens material.¹⁷ Biofilm formation is a critical virulence mechanism because once the fungus establishes a structured community on a surface, it becomes substantially harder for disinfectants and antifungals to kill it. The outbreak led to product recalls and changes in how lens care solutions are tested, but it also underscored how a normally soil-dwelling fungus could exploit manufactured products to reach the human eye.

Why Fusarium Is So Hard to Treat

Perhaps the most frustrating aspect of Fusarium infections is the organism’s inherent resistance to most antifungal drugs. Existing antifungals generally show poor activity against Fusarium species in lab tests, though the relationship between lab results and clinical outcomes is not straightforward.¹³ In one case series, half of the patients had blood cancers, and the inherently high minimum doses needed to inhibit the fungus made treatment a serious challenge.¹⁴

On the agricultural side, F. solani has developed resistance to several major fungicide classes including triazoles, phenylpyrroles, and benzimidazoles in different regions around the world.¹⁸ Researchers studying resistance to specific fungicides have found that point mutations in particular genes can alter drug binding, though the practical risk varies by compound. For the fungicide prochloraz, resistant mutants grew more slowly and reproduced less effectively than normal strains, suggesting that resistance comes at a biological cost and may not spread rapidly in the field.¹⁹ For pydiflumetofen, an SDHI fungicide, resistant mutants maintained fitness comparable to their parent strains, a more worrying finding because it means resistance could persist without a competitive penalty.²⁰

For human infections, the outcome largely depends on whether the patient’s immune system can recover. In animal models of infection, only the combination of voriconazole plus amphotericin B prolonged survival compared to untreated controls, and even that combination only reduced the fungal burden in some organs for one of the two strains tested.²¹ In severe keratitis cases that don’t respond to drug therapy, corneal transplant surgery becomes necessary to physically remove the infection and try to preserve the eye.²² One successful treatment protocol combined penetrating keratoplasty with intravenous and topical voriconazole, using the intravenous formulation as a 1 percent eyedrop solution applied every hour to achieve high concentrations directly at the infection site.²³

Shared Genetic Toolkits for Attacking Plants and Animals

One of the more fascinating questions about the FSSC is how a single group of fungi can infect such wildly different hosts. The answer seems to lie in the organization of their genomes. Comparative genomic work has revealed that FSSC chromosomes are compartmentalized, with some regions evolving slowly and handling basic housekeeping functions while others are packed with repetitive DNA elements and genes related to pathogenicity and niche expansion. These fast-evolving regions contain many of the genes the fungus uses to attack hosts.²⁴

When researchers infected turtle eggs with F. falciforme and F. keratoplasticum, two species from the complex, the most strongly activated genes during infection included those encoding CFEM domain proteins, which are also associated with plant pathogenicity.²⁴ In other words, some of the same molecular tools the fungus uses to invade plant tissue get switched on when it encounters animal cells. This overlap suggests that cross-kingdom pathogenicity was not a recent evolutionary accident but something deeply embedded in the lineage’s genome architecture, traceable to the common ancestor of the Fusarium genus.

Biological Alternatives for Crop Protection

Given the resistance issues with chemical fungicides, biological control agents have become an important part of managing F. solani in agriculture. The best-studied is Trichoderma harzianum, a fast-growing soil fungus that directly inhibits Fusarium growth. In lab tests, T. harzianum reduced F. solani’s growth by about 75 percent, outperforming other Trichoderma species tested.²⁵ Field trials in peanut confirmed that T. harzianum was the most effective biocontrol agent against F. solani brown root rot in both naturally infested and artificially contaminated soils.²⁶

Combinations of biocontrol organisms tend to work better than single agents. Treating squash with mycorrhizal fungi, Trichoderma, and the bacterium Bacillus subtilis together produced the greatest reduction in disease severity and the largest increases in yield across multiple growing seasons.²⁵ Even nitrogen-fixing bacteria normally associated with legumes have shown promise. Coating soybean seeds with Rhizobium japonicum improved germination and significantly reduced root rot caused by F. solani, both in pots and under field conditions.²⁷ These approaches are not silver bullets, but they provide options when chemical fungicides are failing or when growers need alternatives for organic production.

Identifying Fusarium in the Lab

Accurate identification of Fusarium species is harder than it sounds. Under the microscope, many species within the FSSC look similar, and traditional culture methods can miss the distinctions that matter for predicting drug susceptibility or tracing an outbreak’s source. Molecular sequencing of conserved gene regions remains the gold standard for placing an isolate within the complex.¹

A faster alternative gaining ground in clinical labs is MALDI-TOF mass spectrometry, which identifies microorganisms by their protein profiles. The technology is already well established for bacteria and yeasts, and results for Fusarium are promising, with identification rates to the species level ranging from 82 to 99 percent depending on the system and reference database used.²⁸ The catch is that these databases are still being expanded. A clinical lab using a commercial system with a limited Fusarium library may misidentify a less common species or only get as far as “Fusarium species complex” without pinpointing which one.

New Drugs in the Pipeline

The dismal track record of existing antifungals against Fusarium has pushed researchers to test new compounds. A large in vitro study evaluating novel antifungals against molecularly identified Fusarium isolates from multiple species complexes found that two newer drugs, manogepix and natamycin, showed broad activity against Fusarium species generally. Two others, rezafungin and ibrexafungerp, had essentially no effect.²⁹ Olorofim, which targets a completely different metabolic pathway than conventional antifungals, showed a mixed profile: it worked well against some Fusarium species complexes but FSSC isolates showed high minimum inhibitory concentrations, meaning the drug was less effective against the group most commonly involved in human disease.²⁹ An earlier study had been more optimistic about olorofim’s potential against FSSC isolates, though the MIC range was higher than for F. oxysporum.³⁰

None of these drugs have yet been approved specifically for fusariosis, and lab activity does not always predict how a drug performs in a patient. But the pipeline is broader than it has been in years, and manogepix in particular has generated interest because it targets a different step in fungal cell-surface assembly than any currently available drug. For an organism whose hallmark is shrugging off the drugs we already have, new mechanisms of action are the most hopeful development.

1
PubMed Central. Morphological and phylogenetic analysis of Fusarium solani species complex in Malaysia
2
PubMed. Phylogenetic relationships among members of the Fusarium solani species complex in human infections and the descriptions of F. keratoplasticum sp. nov. and F. petroliphilum stat. nov.
3
PubMed Central. Widespread occurrence of diverse human pathogenic types of the fungus Fusarium detected in plumbing drains
4
PubMed. Fusarium species recovered from the water distribution system of a French university hospital
5
PubMed. Sewage and community shower drains are environmental reservoirs of Fusarium solani species complex group 1, a human and plant pathogen
6
Journal of Hospital Infection. Drain outlets in patient rooms as sources for invasive fusariosis: an analysis of patients with haematological disorders
7
PubMed. First Report of Fusarium solani Causing Crown and Root Rot on Strawberry Crops in Southwestern Spain
8
Journal of General Plant Pathology. Characterization and pathogenicity of Fusarium solani associated with dry root rot of citrus in the eastern Mediterranean region of Turkey
9
PubMed. Hormonal regulation and cell wall-degrading enzymes: dual strategies of Fusarium solani in passion fruit stem rot pathogenesis
10
PubMed Central. Fusarium infections in immunocompromised patients
11
PubMed Central. A case of fungal keratitis due to Fusarium solani after an indigenous healing practice
12
PubMed Central. Fusarium solani Activates PANoptosis and Modulates Immune Response in Fungal Keratitis
13
PubMed Central. Invasive fusariosis
14
PubMed Central. Clinical Features and Outcomes of Invasive Fusariosis: A Case Series in a Single Center with Literature Review
15
PubMed Central. In the aftermath of the Fusarium keratitis outbreak: What have we learned?
16
PubMed. Animal models to investigate fungal biofilm formation
17
PubMed Central. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions
18
PubMed. Fungicide resistance in Fusarium species: exploring environmental impacts and sustainable management strategies
19
PubMed. Resistance risk and mechanism of prochloraz in Fusarium solani
20
PubMed. Resistance to the SDHI Fungicide Pydiflumetofen in Fusarium solani: Risk Assessment and Resistance-Related Point Mutation in FsSdhC Gene
21
PubMed. Combined therapy in treatment of murine infection by Fusarium solani
22
PubMed Central. Therapeutic Keratoplasty for Fusarium Keratitis
23
Clinical Infectious Diseases. Successful Treatment of Fusarium Keratitis with Cornea Transplantation and Topical and Systemic Voriconazole
24
PubMed Central. Comparative genomic and transcriptomic analyses of trans-kingdom pathogen Fusarium solani species complex reveal degrees of compartmentalization
25
Egyptian Journal of Biological Pest Control. Biocontrol of Fusarium root rot in squash using mycorrhizal fungi and antagonistic microorganisms
26
Crop Protection. Biological control by Trichoderma species of Fusarium solani causing peanut brown root rot under field conditions
27
Plant Protection Science. Rhizobium japonicum as a biocontrol agent of soybean root rot disease caused by Fusarium solani and Macrophomina phaseolina
28
PubMed Central. Diagnosis of Fusarium Infections: Approaches to Identification by the Clinical Mycology Laboratory
29
PubMed Central. In vitro activity of novel antifungals, natamycin, and terbinafine against Fusarium
30
PubMed. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes